MNMD RSI Chart
Last 7 days
-11.1%
Last 30 days
-13.6%
Last 90 days
67.3%
Trailing 12 Months
161.3%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 25, 2024 | karlin dan | sold | -62,491 | 9.5 | -6,578 | chief medical officer |
Mar 25, 2024 | greenway schond l. | sold (taxes) | -54,376 | 9.78 | -5,560 | chief financial officer |
Mar 25, 2024 | barrow robert | sold | -156,930 | 9.5 | -16,519 | chief executive officer |
Dec 26, 2023 | barrow robert | sold | -48,050 | 3.63 | -13,237 | chief executive officer |
Dec 26, 2023 | karlin dan | sold | -24,589 | 3.63 | -6,774 | chief medical officer |
Dec 26, 2023 | greenway schond l. | sold | -20,516 | 3.63 | -5,652 | chief financial officer |
Sep 25, 2023 | karlin dan | sold | -24,729 | 3.57468 | -6,918 | chief medical officer |
Sep 25, 2023 | barrow robert | sold | -48,273 | 3.5761 | -13,499 | chief executive officer |
Sep 25, 2023 | greenway schond l. | sold | -20,608 | 3.57669 | -5,762 | chief financial officer |
Aug 25, 2023 | greenway schond l. | sold | -76,000 | 3.8 | -20,000 | chief financial officer |
Which funds bought or sold MNMD recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | Ikarian Capital, LLC | reduced | -50.42 | 600,322 | 2,796,320 | 0.31% |
May 17, 2024 | VIMA LLC | added | 205 | 114 | 184 | -% |
May 16, 2024 | JANE STREET GROUP, LLC | added | 239 | 3,099,750 | 3,501,110 | -% |
May 16, 2024 | AWM Investment Company, Inc. | new | - | 7,830,200 | 7,830,200 | 1.02% |
May 16, 2024 | Tidal Investments LLC | new | - | 1,697,640 | 1,697,640 | 0.03% |
May 15, 2024 | MARSHALL WACE, LLP | new | - | 18,786,300 | 18,786,300 | 0.03% |
May 15, 2024 | GTS SECURITIES LLC | new | - | 234,257 | 234,257 | -% |
May 15, 2024 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | added | 2,200 | 3,400 | 3,459 | -% |
May 15, 2024 | Royal Bank of Canada | added | 654 | 361,000 | 381,000 | -% |
May 15, 2024 | JANUS HENDERSON GROUP PLC | new | - | 8,964,260 | 8,964,260 | -% |
Unveiling Mind Medicine's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Mind Medicine News
Balance Sheet | ||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2020Q4 |
Assets | 121.2% | 276 | 125 | 142 | 142 | 156 | 170 | 181 | 134 | 149 | 164 | 82.00 |
Current Assets | 145.9% | 255 | 104 | 120 | 120 | 132 | 146 | 157 | 109 | 123 | 137 | 82.00 |
Cash Equivalents | 153.1% | 252 | 100 | 118 | 117 | 129 | 142 | 155 | 106 | 120 | 134 | 80.00 |
Goodwill | 0% | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | - |
Liabilities | 71.3% | 79.00 | 46.00 | 46.00 | 36.00 | 25.00 | 19.00 | 27.00 | 10.00 | 12.00 | 12.00 | 6.00 |
Current Liabilities | 102.4% | 65.00 | 32.00 | 31.00 | 35.00 | 24.00 | 18.00 | 26.00 | 8.00 | 11.00 | 10.00 | 3.00 |
Shareholder's Equity | 150.9% | 196 | 78.00 | 96.00 | 106 | 130 | 151 | 154 | 125 | 137 | 152 | 76.00 |
Retained Earnings | -18.7% | -344 | -290 | -266 | -248 | -219 | -194 | -189 | -173 | -156 | -137 | -44.64 |
Additional Paid-In Capital | 46.7% | 540 | 368 | 362 | 354 | 349 | 345 | 342 | 297 | 292 | 288 | 120 |
Shares Outstanding | 73.1% | 71.00 | 41.00 | 40.00 | 39.00 | 38.00 | 38.00 | 29.00 | 28.00 | 28.00 | 28.00 | 18.00 |
Float | - | - | - | - | 140 | - | - | - | 272 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2019Q4 |
Cashflow From Operations | 19.3% | -16,598 | -20,563 | -16,626 | -13,845 | -13,331 | -12,849 | -9,297 | -15,127 | -12,866 | -7,833 | -16,782 | -11,171 | -10,038 | - | - |
Share Based Compensation | -100.0% | - | 3,676 | 4,226 | 3,842 | 3,750 | 1,376 | 4,286 | 4,253 | 3,792 | 4,344 | 4,105 | 32,988 | 1,279 | - | - |
Cashflow From Investing | - | - | - | - | - | - | - | - | - | - | 113 | -27.00 | -67.00 | -316 | - | - |
Cashflow From Financing | 6427.1% | 169,247 | 2,593 | 17,398 | 1,274 | 583 | 416 | 58,211 | 590 | -166 | 127 | 820 | 7,889 | 89,988 | - | - |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development | $ 11,705 | $ 12,599 |
General and administrative | 10,499 | 8,263 |
Total operating expenses | 22,204 | 20,862 |
Loss from operations | (22,204) | (20,862) |
Other income/(expense): | ||
Interest income | 1,656 | 1,360 |
Interest expense | (434) | (76) |
Foreign exchange loss, net | (525) | (52) |
Change in fair value of 2022 USD Financing Warrants | (32,893) | (5,185) |
Total other expense, net | (32,196) | (3,953) |
Net loss | (54,400) | (24,815) |
Other comprehensive loss | ||
Gain on foreign currency translation | 493 | 14 |
Comprehensive loss | $ (53,907) | $ (24,801) |
Net loss per common share, basic | $ (1.14) | $ (0.65) |
Net loss per common share, diluted | $ (1.14) | $ (0.65) |
Weighted-average common shares, basic | 47,860,757 | 38,077,251 |
Weighted-average common shares, diluted | 47,860,757 | 38,077,251 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 252,332 | $ 99,704 |
Prepaid and other current assets | 3,139 | 4,168 |
Total current assets | 255,471 | 103,872 |
Goodwill | 19,918 | 19,918 |
Intangible assets, net | 527 | |
Other non-current assets | 144 | 224 |
Total assets | 275,533 | 124,541 |
Current liabilities: | ||
Accounts payable | 7,595 | 4,136 |
Accrued expenses | 9,974 | 11,634 |
2022 USD Financing Warrants | 47,700 | 16,476 |
Total current liabilities | 65,269 | 32,246 |
Credit facility, long-term | 14,190 | 14,129 |
Other liabilities, long-term | 15 | 32 |
Total liabilities | 79,474 | 46,407 |
Commitments and contingencies (Note 9) | ||
Shareholders' Equity: | ||
Common shares, no par value, unlimited authorized as of March 31, 2024 and December 31, 2023; 71,163,720 and 41,101,303 issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | ||
Additional paid-in capital | 539,823 | 367,991 |
Accumulated other comprehensive income | 836 | 343 |
Accumulated deficit | (344,600) | (290,200) |
Total shareholders' equity | 196,059 | 78,134 |
Total liabilities and shareholders' equity | $ 275,533 | $ 124,541 |